Ozden I, Emre A, Alper A, Tunaci M, Acarli K, Bilge O, Tekant Y, Ariogul O
Ataköy 9. Kisim, A2B Blok D 123, Istanbul 34750, Turkey.
Arch Surg. 2000 Aug;135(8):978-81. doi: 10.1001/archsurg.135.8.978.
Elective surgery for liver hemangiomas is still controversial.
Long-term results show that elective surgery for liver hemangiomas is safe and effective.
A tertiary care university hospital in Istanbul, Turkey.
Forty-two patients underwent surgery for liver hemangiomas between January 1988 and December 1998; 41 were symptomatic. The primary indications for surgery were abdominal pain in 33 patients, diagnostic uncertainty in 6, and enlargement in 3. The median largest dimension of the major lesion was 10 cm (range, 7-45 cm).
(1) Patients' assessment of the effects of surgery on preoperative symptoms, (2) determination of whether any other pathological conditions were missed in the preoperative evaluation, (3) operative mortality and morbidity, and (4) recurrences.
Retrospective cohort study.
Enucleation was the most frequent operation (33 patients). Hospital mortality and morbidity were 2.4% (bleeding from the biopsy site on a lesion evaluated as inoperable at laparotomy; 1 patient) and 12% (5 patients), respectively. Thirty-three patients could be followed up for a median of 53 months (range, 6-135 months). Of the 32 preoperatively symptomatic patients, surgery was successful in symptom control in 28 (88%) (complete resolution or significant amelioration). No other cause of pain could be identified during follow-up in the other patients. Control ultrasonography revealed no recurrences.
Elective surgery is indicated in a small subset of patients with hemangiomas because of abdominal pain, enlargement, and diagnostic uncertainty. The results of surgery in symptom control are gratifying in approximately 90% of patients. Recurrences are rare. Enucleation can be performed rapidly and safely in most patients and should be preferred to resection.
肝血管瘤的择期手术仍存在争议。
长期结果表明,肝血管瘤的择期手术是安全有效的。
土耳其伊斯坦布尔的一家三级护理大学医院。
1988年1月至1998年12月期间,42例患者接受了肝血管瘤手术;41例有症状。手术的主要指征为33例患者腹痛,6例诊断不明确,3例肿瘤增大。主要病变的最大直径中位数为10 cm(范围7 - 45 cm)。
(1)患者对手术对术前症状影响的评估;(2)确定术前评估中是否遗漏任何其他病理状况;(3)手术死亡率和发病率;(4)复发情况。
回顾性队列研究。
摘除术是最常见的手术方式(33例患者)。医院死亡率和发病率分别为2.4%(剖腹探查时被评估为无法手术切除的病变活检部位出血;1例患者)和12%(5例患者)。33例患者可进行随访,随访时间中位数为53个月(范围6 - 135个月)。32例术前有症状的患者中,28例(88%)手术成功控制了症状(完全缓解或显著改善)。随访期间,其他患者未发现其他疼痛原因。超声检查未发现复发。
由于腹痛、肿瘤增大和诊断不明确,一小部分血管瘤患者适合进行择期手术。约90%的患者手术控制症状的效果令人满意。复发罕见。大多数患者可快速、安全地进行摘除术,应优先于切除术。